These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 34442398)

  • 1. Breast Cancer Cell-Derived Adenosine Enhances Generation and Suppressor Function of Human Adaptive Regulatory T Cells.
    Mandapathil M; Szczepanski MJ; Jackson EK; Lang S; Whiteside TL
    J Pers Med; 2021 Jul; 11(8):. PubMed ID: 34442398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenosine and prostaglandin E2 cooperate in the suppression of immune responses mediated by adaptive regulatory T cells.
    Mandapathil M; Szczepanski MJ; Szajnik M; Ren J; Jackson EK; Johnson JT; Gorelik E; Lang S; Whiteside TL
    J Biol Chem; 2010 Sep; 285(36):27571-80. PubMed ID: 20558731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human CD4+ CD39+ regulatory T cells produce adenosine upon co-expression of surface CD73 or contact with CD73+ exosomes or CD73+ cells.
    Schuler PJ; Saze Z; Hong CS; Muller L; Gillespie DG; Cheng D; Harasymczuk M; Mandapathil M; Lang S; Jackson EK; Whiteside TL
    Clin Exp Immunol; 2014 Aug; 177(2):531-43. PubMed ID: 24749746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased ectonucleotidase expression and activity in regulatory T cells of patients with head and neck cancer.
    Mandapathil M; Szczepanski MJ; Szajnik M; Ren J; Lenzner DE; Jackson EK; Gorelik E; Lang S; Johnson JT; Whiteside TL
    Clin Cancer Res; 2009 Oct; 15(20):6348-57. PubMed ID: 19825957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation and immunosuppressive functions of p53-induced human adaptive regulatory T cells.
    Mandapathil M; Visus C; Finn OJ; Lang S; Whiteside TL
    Oncoimmunology; 2013 Jul; 2(7):e25514. PubMed ID: 24073385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenosine metabolism of human mesenchymal stromal cells isolated from patients with head and neck squamous cell carcinoma.
    Schuler PJ; Westerkamp AM; Kansy BA; Bruderek K; Dissmann PA; Dumitru CA; Lang S; Jackson EK; Brandau S
    Immunobiology; 2017 Jan; 222(1):66-74. PubMed ID: 26898925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic and functional characteristics of CD39
    Figueiró F; Muller L; Funk S; Jackson EK; Battastini AM; Whiteside TL
    Oncoimmunology; 2016 Feb; 5(2):e1082703. PubMed ID: 27057473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenosine-generating ovarian cancer cells attract myeloid cells which differentiate into adenosine-generating tumor associated macrophages - a self-amplifying, CD39- and CD73-dependent mechanism for tumor immune escape.
    Montalbán Del Barrio I; Penski C; Schlahsa L; Stein RG; Diessner J; Wöckel A; Dietl J; Lutz MB; Mittelbronn M; Wischhusen J; Häusler SFM
    J Immunother Cancer; 2016; 4():49. PubMed ID: 27532024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ATP and Its Metabolite Adenosine as Regulators of Dendritic Cell Activity.
    Silva-Vilches C; Ring S; Mahnke K
    Front Immunol; 2018; 9():2581. PubMed ID: 30473700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenosine and the adenosine A2A receptor agonist, CGS21680, upregulate CD39 and CD73 expression through E2F-1 and CREB in regulatory T cells isolated from septic mice.
    Bao R; Shui X; Hou J; Li J; Deng X; Zhu X; Yang T
    Int J Mol Med; 2016 Sep; 38(3):969-75. PubMed ID: 27430240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation and accumulation of immunosuppressive adenosine by human CD4+CD25highFOXP3+ regulatory T cells.
    Mandapathil M; Hilldorfer B; Szczepanski MJ; Czystowska M; Szajnik M; Ren J; Lang S; Jackson EK; Gorelik E; Whiteside TL
    J Biol Chem; 2010 Mar; 285(10):7176-86. PubMed ID: 19858205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Multifaceted Actions of CD73 During Development and Suppressive Actions of Regulatory T Cells.
    Da M; Chen L; Enk A; Ring S; Mahnke K
    Front Immunol; 2022; 13():914799. PubMed ID: 35711418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenosine production by human B cells and B cell-mediated suppression of activated T cells.
    Saze Z; Schuler PJ; Hong CS; Cheng D; Jackson EK; Whiteside TL
    Blood; 2013 Jul; 122(1):9-18. PubMed ID: 23678003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenosine can thwart antitumor immune responses elicited by radiotherapy : Therapeutic strategies alleviating protumor ADO activities.
    Vaupel P; Multhoff G
    Strahlenther Onkol; 2016 May; 192(5):279-87. PubMed ID: 26961686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting human inducible regulatory T cells (Tr1) in patients with cancer: blocking of adenosine-prostaglandin E₂ cooperation.
    Mandapathil M; Whiteside TL
    Expert Opin Biol Ther; 2011 Sep; 11(9):1203-14. PubMed ID: 21702720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of the adenosinergic pathway in immunosuppression mediated by human regulatory T cells (Treg).
    Whiteside TL; Mandapathil M; Schuler P
    Curr Med Chem; 2011; 18(34):5217-23. PubMed ID: 22087822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD73 and CD39 ectonucleotidases in T cell differentiation: Beyond immunosuppression.
    Bono MR; Fernández D; Flores-Santibáñez F; Rosemblatt M; Sauma D
    FEBS Lett; 2015 Nov; 589(22):3454-60. PubMed ID: 26226423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expansion and characteristics of human T regulatory type 1 cells in co-cultures simulating tumor microenvironment.
    Bergmann C; Strauss L; Zeidler R; Lang S; Whiteside TL
    Cancer Immunol Immunother; 2007 Sep; 56(9):1429-42. PubMed ID: 17265021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenosine production in mesenchymal stromal cells in relation to their developmental status.
    Jeske SS; Theodoraki MN; Boelke E; Laban S; Brunner C; Rotter N; Jackson EK; Hoffmann TK; Schuler PJ
    HNO; 2020 Feb; 68(2):87-93. PubMed ID: 31915882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preventing ATP Degradation by ASO-Mediated Knockdown of CD39 and CD73 Results in A2aR-Independent Rescue of T Cell Proliferation.
    Festag J; Thelemann T; Schell M; Raith S; Michel S; Jaschinski F; Klar R
    Mol Ther Nucleic Acids; 2020 Sep; 21():656-669. PubMed ID: 32739778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.